EcoDrugPlus

Emap Like 4

Ensembl ID : ENSPLAG00000000249
Gene Symbol: EML4
2 Cross references
206 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSPLAG00000012481
Gene Symbol: EPHA3
1 Cross references
169 Possible Orthologues:

F2r Like Thrombin Or Trypsin Receptor 3

Ensembl ID : ENSPLAG00000023994
Gene Symbol: F2RL3
2 Cross references
195 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSPLAG00000007110
Gene Symbol: FAU
3 Cross references
300 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSPLAG00000024003
Gene Symbol: FYN
4 Cross references
196 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSPLAG00000019774
Gene Symbol: GPR119
4 Cross references
173 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSPLAG00000002439
Gene Symbol: GPR119
4 Cross references
173 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSPLAG00000008023
Gene Symbol: GPR84
1 Cross references
108 Possible Orthologues:

G-Protein Coupled Receptor 84-Like

Ensembl ID : ENSPLAG00000008012
Gene Symbol: LOC106954436
3 Cross references
108 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSPLAG00000007022
Gene Symbol: HCK
3 Cross references
202 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSPLAG00000010016
Gene Symbol: ITK
3 Cross references
205 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSPLAG00000000109
Gene Symbol: JAK1
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).